Abiocode Logo
Products
Contact Us
- Telephone:
1-818-707-0309 - E-Mail:
Abiocode@Abiocode.com
R0837-vp - SOX9 (vPairTM) Antibodies
|
Predicted | Observed MW: 56 | 70 kDa Uniprot ID: P48436 Application: WB Quantity: 50 ul SOX9 (M) (R0837-2) Rabbit Polyclonal Antibody & 50 ul SOX9 (C) (R0837-3) Rabbit Polyclonal Antibody Product Introduction: vPairTM antibodies represent a pair of fully characterized antibodies that recognize two different regions of a target protein. The product is developed by Abiocode to address whether the signal observed truly represents the protein of interest, an often encountered issue in antibody-based assays. The use of a pair of fully characterized vPairTM antibodies in the same assay can validate signal specificity since vPairTM antibodies recognize two independent epitopes of the same protein. Different sets of vPairTM antibodies are developed at Abiocode to work with specific applications, including antibody arrays, Western blot, IP-Western, ChIP, IHC, and FACS. Background: Transcription factor SOX-9 is a nucleic protein that plays an important role in the normal skeletal development. SOX9 contains 1 HMG box DNA-binding domain. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Defects in SOX9 are the cause of campomelic dysplasia (CMD1) and 46,XX sex reversal type 2 (SRXX2). Other Names: Transcription factor SOX-9 Source and Purity: Rabbit polyclonal antibodies were produced by immunizing animals with a GST-fusion protein containing either the middle [SOX9 (M) (R0837-2)] or the C-terminal [SOX9 (C) (R0837-3)] region of human SOX9. Antibodies were purified by affinity purification using immunogen. Storage Buffer and Condition: Supplied in 1 x PBS (pH 7.4), 100 ug/ml BSA, 40% Glycerol, 0.01% NaN3. Store at -20 °C. Stable for 6 months from date of receipt. Species Specificity: Human Tested Applications: WB: 1:500-1:2,000 (detect endogenous protein*) *: The apparent protein size on WB may be different from the calculated M.W. due to modifications. Product Data: Fig 1. Western blot of total cell extracts from human HepG2, using (A) Ab (R0837-2) and (B) Ab (R0837-3) at RT for 2 h. |